Status:
COMPLETED
Theta Burst Stimulation for Alcohol Use Disorder
Lead Sponsor:
Gopalkumar Rakesh
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Alcohol Use Disorder
Eligibility:
All Genders
21-60 years
Phase:
NA
Brief Summary
The study will examine the effects of two continuous theta burst stimulation (cTBS) sessions (given in a single day) on resting state functional MRI (fMRI), alcohol cue related attentional bias and al...
Detailed Description
Although pharmacotherapy and behavioral treatments have been approved for AUD, their effects sizes are modest. Noninvasive neuromodulation like Transcranial magnetic stimulation (TMS) can offer an alt...
Eligibility Criteria
Inclusion
- Inclusion criteria.
- Patients seen at a clinic within the University of Kentucky Healthcare
- 21-60 years of age
- male or female gender
- Able to read, understand and communicate in English
- willing to adhere to the general rules of the UK Healthcare
- Must fulfill criteria for moderate alcohol use disorder.
- Exclusion criteria
- Positive pregnancy test for females
- traumatic brain injury, history of seizure disorder, history of or current diagnosis of schizophrenia
- intracranial metal shrapnel
- previous adverse effect with TMS
- sub-threshold consistency while performing behavioral tasks
- failure to show baseline attentional bias to alcohol versus neutral cues.
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 17 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06060496
Start Date
October 1 2023
End Date
April 17 2024
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
245 Fountain Court
Lexington, Kentucky, United States, 40513